John Craig Thompson, Chief Operating Officer at TETRAPHASE PHARMACEUTICALS INC (TTPH), sold 30,000 shares at $39.63 ($1.2M) on 2015-05-15, disclosed to the SEC on 2015-05-19.
Scheduled sale ($1.2M) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TTPH | SELL | 2015-08-07 | $463K | — | Filing → |
| TTPH | SELL | 2015-07-08 | $479K | — | Filing → |
| TTPH | SELL | 2015-06-16 | $415K | — | Filing → |